THE Food and Drug Administration (FDA) yesterday warned the public about the presence of counterfeit versions of nine drug products that are usually available over-the-counter.
FDA Advisory Nos. 2023-0762, 2023-0763, 2023-0764 listed fake products for the following drugs: Mefenamic Acid (Ponstan®) 500 mg tablet, Loperamide Hydrochloride (Diatabs®) 2 mg capsule, Aluminum Hydroxide/Magnesium Hydroxide/Simeticone (Kremil-S®) 178 mg/233 mg/30 mg chewable tablet, Ibuprofen (Medicol® Advance) 200 mg soft gel capsule, Loperamide HCl (Lomotil) 2 mg tablet, Ibuprofen/Paracetamol (Alaxan®FR) 200 mg/325 mg capsule, Phenylephrine Hydrochloride/Chlorphenamine Maleate/Paracetamol (Neozep®Forte) 10 mg/2 mg/500 mg, Phenylephrine Hydrochloride/Chlorphenamine Maleate/Paracetamol (Bioflu®) 10 mg /2 mg/500 mg film-coated tablet, and Dextromethorphan HBr/Phenylpropanolamine HCl/Paracetamol (Tuseran®Forte).
“Anyone found selling the said counterfeit drug products will be penalized,” the FDA said.
It asked local government units and law enforcement agencies to ensure that the fake products “are not sold or made available in their localities or areas of jurisdiction.” — Gerard Naval
